Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial.

JP, Neoptolemos; DD, Stocken; JA, Dunn; J, Almond; HG, Beger; P, Pederzoli; C, Bassi; C, Dervenis; L, Fernandez-Cruz; F, Lacaine; J, Buckels; M, Deakin; FA, Adab; R, Sutton; C, Imrie; I, Ihse; T, Tihanyi; A, Olah; S, Pedrazzoli; D, Spooner; DJ, Kerr; H, Friess; MW, Büchler

doi:10.1097/00000658-200112000-00007

Public

Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial.

Shared by NobleBlocks on Dec 1, 2001 • 12:00 AM UTC

Authors:

Neoptolemos JP

Stocken DD

Dunn JA

Abstract

Objective To assess the influence of resection margins on survival for patients with resected pancreatic cancer treated within the context of the adjuvant European Study Group for Pancreatic Cancer-1 (ESPAC-1) study.Summary background data Pancreatic cancer is associated with a poor long-term surviv...

Discussions